Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-center, Observational, Non-interventional, Prospective Study of the Efficacy of Azilsartan Medoxomil in Patients With Arterial Hypertension Associated With Stable Ischemic Heart Disease and Type 2 Diabetes Mellitus.

NCT03539627 is registered in ClinicalTrials.gov with Research Institute for Complex Problems of Cardiovascular Diseases, Russia as lead sponsor.

NCT NCT03539627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03539627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-center, Observational, Non-interventional, Prospective Study of the Efficacy of Azilsartan Medoxomil in Patients With Arterial Hypertension Associated With Stable Ischemic Heart Disease and Type 2 Diabetes Mellitus.
Lead sponsor
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Phase
Observational
Overall status
Completed
Start date
November 7, 2018
Completion date
April 29, 2022
Enrollment
184 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, diabetes mellitus, stable chronic angina